BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8962278)

  • 1. Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
    Kyriakopoulos G; Antoniadis A; Gakis D; Papanikolaou V
    Transplant Proc; 1996 Dec; 28(6):3294-5. PubMed ID: 8962278
    [No Abstract]   [Full Text] [Related]  

  • 2. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract]   [Full Text] [Related]  

  • 3. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 4. Do early cyclosporine levels affect the incidence of acute rejection in renal transplant recipients?
    Johnson EM; Canafax DM; Gillingham K; Schmidt W; Pandian K; Najarian JS; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):879. PubMed ID: 8623444
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic rejection of renal allografts with four immunosuppressive regimens.
    Isoniemi H; Ahonen J; Krogerus L; Eklund B; Höckerstedt K; Salmela K; Häyry P
    Transplant Proc; 1992 Dec; 24(6):2716-7. PubMed ID: 1465912
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection.
    Renna Molajoni E; Cinti P; Evangelista B; Poli L; Cocciolo P; Berloco P; Cortesini R
    Transplant Proc; 1996 Feb; 28(1):402-3. PubMed ID: 8644290
    [No Abstract]   [Full Text] [Related]  

  • 7. Chagas disease and transplantation.
    Vazquez MC; Sabbatiello R; Schiavelli R; Maiolo E; Jacob N; Pattin M; Rearte A
    Transplant Proc; 1996 Dec; 28(6):3301-3. PubMed ID: 8962281
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of postdose cyclosporine monitoring in living renal transplant recipients.
    Thomas R; Minz M; Singh B; Heer M; Kashyap R
    Transplant Proc; 2004 Sep; 36(7):2104. PubMed ID: 15518761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
    Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated acute rejection in renal allograft.
    Han DJ; Yoon HS; Lee HM
    Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
    Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J
    Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
    Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
    [No Abstract]   [Full Text] [Related]  

  • 15. Increasing incidence of steroid resistant rejection in kidney transplantation.
    Arrazola L; Sozen H; Humar A; Papalois V; Uknis M; Matas AJ
    Transplant Proc; 2000 Nov; 32(7):1767. PubMed ID: 11119926
    [No Abstract]   [Full Text] [Related]  

  • 16. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients.
    Roth D; Miller J
    Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204
    [No Abstract]   [Full Text] [Related]  

  • 17. Toward optimal induction with cyclosporine therapy.
    Pfaff WW; Howard RJ; Patton PR; Peterson JC; Fennell RS; Karlix JL; Reed AI; Rosen CB; Scornik JC
    Transplant Proc; 1996 Aug; 28(4):2109-10. PubMed ID: 8769169
    [No Abstract]   [Full Text] [Related]  

  • 18. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry crossmatch: a sensitive technique for assessment of acute rejection in renal transplantation.
    Piazza A; Adorno D; Poggi E; Borrelli L; Buonomo O; Pisani F; Valeri M; Torlone N; Camplone C; Monaco PI; Fraboni D; Casciani CU
    Transplant Proc; 1998 Aug; 30(5):1769-71. PubMed ID: 9723274
    [No Abstract]   [Full Text] [Related]  

  • 20. Transplantation in Singapore.
    Vathsala A; Lee WT; Li MK; Woo KT; Lim CH
    Transplant Proc; 1995 Feb; 27(1):1472-5. PubMed ID: 7878947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.